Literature DB >> 2020852

Progress toward malaria preerythrocytic vaccines.

S L Hoffman1, V Nussenzweig, J C Sadoff, R S Nussenzweig.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2020852     DOI: 10.1126/science.2020852

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  7 in total

Review 1.  Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design.

Authors:  Javier E Garcia; Alvaro Puentes; Manuel E Patarroyo
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

2.  Phase I safety and immunogenicity trial of Plasmodium vivax CS derived long synthetic peptides adjuvanted with montanide ISA 720 or montanide ISA 51.

Authors:  Sócrates Herrera; Olga Lucía Fernández; Omaira Vera; William Cárdenas; Oscar Ramírez; Ricardo Palacios; Mario Chen-Mok; Giampietro Corradin; Myriam Arévalo-Herrera
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

Review 3.  Transgenic and mutant animal models to study mechanisms of protection of red cell genetic defects against malaria.

Authors:  H L Shear
Journal:  Experientia       Date:  1993-01-15

Review 4.  Effect of global warming on the distribution of parasitic and other infectious diseases: a review.

Authors:  G C Cook
Journal:  J R Soc Med       Date:  1992-11       Impact factor: 18.000

5.  Evidence for two-stage binding by the 175-kD erythrocyte binding antigen of Plasmodium falciparum.

Authors:  K C Kain; P A Orlandi; J D Haynes; K L Sim; D E Lanar
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

6.  Framework for Characterizing Longitudinal Antibody Response in Children After Plasmodium falciparum Infection.

Authors:  Eric Rogier; Doug Nace; Pedro R Dimbu; Brian Wakeman; Jan Pohl; James G Beeson; Chris Drakeley; Kevin Tetteh; Mateusz Plucinski
Journal:  Front Immunol       Date:  2021-03-02       Impact factor: 7.561

7.  Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes.

Authors:  Ben C L van Schaijk; Chris J Janse; Geert-Jan van Gemert; Melissa R van Dijk; Audrey Gego; Jean-Francois Franetich; Marga van de Vegte-Bolmer; Samir Yalaoui; Olivier Silvie; Stephen L Hoffman; Andrew P Waters; Dominique Mazier; Robert W Sauerwein; Shahid M Khan
Journal:  PLoS One       Date:  2008-10-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.